327 related articles for article (PubMed ID: 70469)
21. Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals.
Fauci AS; Balow JE; Pratt KR
J Clin Invest; 1976 Apr; 57(4):826-35. PubMed ID: 947955
[TBL] [Abstract][Full Text] [Related]
22. Characterization of Ia8 antigen, thy-1.2 antigen, complement receptors, and virus production in a group of murine virus-induced leukemia cell lines.
Chesebro B; Wehrly K; Chesebro K; Portis J
J Immunol; 1976 Oct; 117(4):1267-74. PubMed ID: 185295
[TBL] [Abstract][Full Text] [Related]
23. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
Christiaansen JE; Sears DW
Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
[TBL] [Abstract][Full Text] [Related]
24. Effector cells in avian spontaneous and antibody-dependent cell-mediated cytotoxicity.
Fleischer B
J Immunol; 1980 Sep; 125(3):1161-6. PubMed ID: 7410832
[TBL] [Abstract][Full Text] [Related]
25. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
26. Human antibody-dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytial virus.
Scott R; de Landazuri MO; Gardner PS; Owen JJ
Clin Exp Immunol; 1977 Apr; 28(1):19-26. PubMed ID: 862248
[TBL] [Abstract][Full Text] [Related]
27. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
[TBL] [Abstract][Full Text] [Related]
28. Identification of murine leukemia viral antigens detected on mouse cells by H-2 alloantisera.
Milner RJ; Henning R; Edelman GM
Eur J Immunol; 1976 Sep; 6(9):603-7. PubMed ID: 187431
[TBL] [Abstract][Full Text] [Related]
29. Differentiation antigens on normal and Abelson virus transformed lymphocytes.
North JR; Raschke WC
J Immunol; 1979 Jun; 122(6):2571-6. PubMed ID: 221587
[TBL] [Abstract][Full Text] [Related]
30. Antibody-dependent cell-mediated cytolysis of human colon carcinoma cells induced by specific antisera against carcinoembryonic antigen.
Carrel S; Delisle MC; Mach JP
Cancer Res; 1977 Aug; 37(8 Pt 1):2644-50. PubMed ID: 872092
[TBL] [Abstract][Full Text] [Related]
31. Production of xenogeneic and allogeneic antisera specific for mouse thymus-derived lymphocytes.
Bron C; Anckers C; Sauser D
Eur J Immunol; 1976 Aug; 6(8):594-8. PubMed ID: 61881
[TBL] [Abstract][Full Text] [Related]
32. Reversal of SV40 tumor-mediated suppression of spleen cell cytotoxicity by antibody.
Prather SO; Lausch RN
J Immunol; 1977 Jan; 118(1):203-10. PubMed ID: 187698
[TBL] [Abstract][Full Text] [Related]
33. Antibody-dependent cytolytically active human leukocytes: an analysis of inactivation following in vitro interaction with antibody-coated target cells.
Ziegler HK; Henney CS
J Immunol; 1975 Dec; 115(6):1500-4. PubMed ID: 1184963
[TBL] [Abstract][Full Text] [Related]
34. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
Fan J; Bonavida B
J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
[TBL] [Abstract][Full Text] [Related]
35. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC).
Christiaansen JE; Burnside SS; Sears DW
J Immunol; 1987 Apr; 138(7):2236-43. PubMed ID: 3549899
[TBL] [Abstract][Full Text] [Related]
36. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes. II. Comparison with polymorphonuclear leukocytes against erythrocyte and nucleated target cells.
Fuson EW; Shaw MW; Hubbard RA; Sugantharaj DG; Lamon EW
Exp Hematol; 1981 Feb; 9(2):197-206. PubMed ID: 7238651
[TBL] [Abstract][Full Text] [Related]
37. Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell.
Trinchieri G; Bauman P; De Marchi M; Tökés Z
J Immunol; 1975 Jul; 115(1):249-55. PubMed ID: 125298
[TBL] [Abstract][Full Text] [Related]
38. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
39. Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors.
Biddle WC; Pancook J; Goldrosen M; Han T; Foon KA; Vaickus L
Cancer Res; 1990 May; 50(10):2991-6. PubMed ID: 2334902
[TBL] [Abstract][Full Text] [Related]
40. Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.
Koszinowski U; Thomssen R
Eur J Immunol; 1975 Apr; 5(4):245-51. PubMed ID: 1086229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
